D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis.

Lina PalaiodimouMaria-Ioanna StefanouEleni BakolaMarianna PapadopoulouPanagiotis KokotisAgathi-Rosa VrettouEleni KapsiaDimitrios PetrasAris AnastasakisNikolaos XifarasEleni KarachaliouGiota TouloumiCharalambos VlachopoulosIoannis N BoletisSotirios GiannopoulosGeorgios TsivgoulisChristina Zompola

Published in: Neurology (2022)

-positive patients with latent or early-FD pathology, which may qualify for enzyme-replacement therapy or chaperone treatment.

Keyphrases

replacement therapy
smoking cessation
heat shock protein
heart failure
left ventricular
heat shock
hypertrophic cardiomyopathy
atrial fibrillation